Arnout Bruggeman

False-positive MOG antibodies in a patient with a slow-progressive intramedullary glioma

Arnout Bruggeman (UGent) , Fleur Cordier (UGent) , Ellen Deolet, Marjan Acou (UGent) , Ingeborg Goethals (UGent) and Guy Laureys (UGent)

(2025) NEUROLOGY. 105(6).

Add to list

Journal Article
A1
open access

Tumefactive Virchow-Robin spaces as a cause of secondary parkinsonism

Arnout Bruggeman (UGent) , Jelle Vandersteene (UGent) and Patrick Santens (UGent)

(2025) MOVEMENT DISORDERS CLINICAL PRACTICE. 13(1). p.261-264

Add to list

Journal Article
A1
open access

Beneficial response to 4-aminopyridine in a case of autosomal recessive spinocerebellar ataxia 23 (SCAR23)

Patrick Santens (UGent) and Arnout Bruggeman (UGent)

(2025) NEUROLOGICAL SCIENCES. 46(6). p.2891-2892

Add to list

Journal Article
A1
open access

Functional neurological disorder in Europe : regional differences in education and health policy

Tereza Serranová, Ilaria Di Vico, Michele Tinazzi, Selma Aybek, Ervina Bilic, Stefanie Binzer, Erlend Bøen, Arnout Bruggeman (UGent) , Christo Bratanov, Veronica Raquel Alheia Cabreira, et al.

(2024) EUROPEAN JOURNAL OF NEUROLOGY. 31(10).

Add to list

Journal Article
A1
open access

Transient complete heart block as a presentation of acute (bacterial) meningitis : a case report

Astrid Declercq, Arnout Bruggeman (UGent) and Hans Vandekerckhove (UGent)

(2024) ACTA CARDIOLOGICA. 79(8). p.959-962

Add to list

Journal Article
A1
open access

Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT) : a double-blind, placebo-controlled, randomised, phase 2 trial

Arnout Bruggeman (UGent) , Charysse Vandendriessche (UGent) , Hannelore Hamerlinck (UGent) , Danny De Looze (UGent) , David J. Tate, Marnik Vuylsteke (UGent) , Lindsey De Commer, Lindsay Devolder, Jeroen Raes, Bruno Verhasselt (UGent) , et al.

(2024) ECLINICALMEDICINE. 71.

Add to list

Journal Article
A1
open access

The spreading and effects of human recombinant α-synuclein preformed fibrils in the cerebrospinal fluid of mice

Charysse Vandendriessche (UGent) , Arnout Bruggeman (UGent) , Joyce Foroozandeh (UGent) , Lien Van Hoecke (UGent) , Pieter Dujardin (UGent) , Junhua Xie, Griet Van Imschoot (UGent) , Elien Van Wonterghem (UGent) , Jonas Castelein (UGent) , Cristiano Lucci, et al.

(2024) ENEURO. 11(3).

Add to list

Journal Article
A1
open access

Gut microbiota regulates blood-cerebrospinal fluid barrier function and Aβ pathology

Junhua Xie, Arnout Bruggeman (UGent) , Clint De Nolf (UGent) , Charysse Vandendriessche (UGent) , Griet Van Imschoot (UGent) , Elien Van Wonterghem (UGent) , Lars Vereecke (UGent) and Roosmarijn Vandenbroucke (UGent)

(2023) EMBO JOURNAL. 42(17).

Add to list

Marked hypotonia : an additional feature of ANO3-related movement disorder

Patrick Santens (UGent) , Arnout Bruggeman (UGent) , Nika Schuermans (UGent) , Hannah Verdin (UGent) and Bart Dermaut (UGent)

(2022) EUROPEAN JOURNAL OF MEDICAL GENETICS. 65(12).

Add to list

Journal Article
A1
open access

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease

Jonas Ghyselinck, Lynn Verstrepen, Frédéric Moens, Pieter Van Den Abbeele, Arnout Bruggeman (UGent) , Jawal Said, Barry Smith, Lynne Ann Barker, Caroline Jordan, Valentina Leta, et al.

(2021) INTERNATIONAL JOURNAL OF PHARMACEUTICS-X. 3.

Academic Bibliography

Arnout Bruggeman

False-positive MOG antibodies in a patient with a slow-progressive intramedullary glioma

Tumefactive Virchow-Robin spaces as a cause of secondary parkinsonism

Beneficial response to 4-aminopyridine in a case of autosomal recessive spinocerebellar ataxia 23 (SCAR23)

Functional neurological disorder in Europe : regional differences in education and health policy

Transient complete heart block as a presentation of acute (bacterial) meningitis : a case report

Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT) : a double-blind, placebo-controlled, randomised, phase 2 trial

The spreading and effects of human recombinant α-synuclein preformed fibrils in the cerebrospinal fluid of mice

Gut microbiota regulates blood-cerebrospinal fluid barrier function and Aβ pathology

Marked hypotonia : an additional feature of ANO3-related movement disorder

Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson's disease

Contents

Support

Contact